Home Search
"life science" - search results
If you're not happy with the results, please do another search
Funds: June 2003
Schroder Ventures raises $402m for third life sciences fund, Altor raises E650m for debut fund, 3i reaches E2.1bn first close for latest fund, ComVentures launches new fund, Swander Pace launches consumer products fund, GTCR Golder Rauner holds first close, Arsenal Capital Partners exceed target, Thayer closes below target…
Germany as a technology powerhouse
Germany's economy is characterised by technological leadership and a tradition of entrepreneurship, according to Wellington Partners. But investment in Germany's technology sector is hampered by an international perception of the country's sluggish economic growth and political gridlock.
Western Europe & Israel: June 2003
Deutsche Bank to sell $550m of collateralized fund obligations, Schroder Ventures closes $400m life sciences fund, UK private equity firms lose faith in non-executive directors and ABN Amro forms new private equity subsidiary…
Latest Deals: 18-24 June 2003
The AltAssets weekly round up of deals done across the world. This week there were 97 active investors in 39 deals and 4 exits across 13 sectors, compared to 92 active investors in 46 deals and six exits the previous week…
Pharmaceutical sector insights – annual report 2002
The healthcare and life sciences sector is currently popular in the private equity arena. Here, PricewaterhouseCoopers outlines the mergers and acquisitions activity in the sector for 2002 and provides an insight into the areas of medical devices and biotechnology.
European wireless investment 2002
Despite the recent high-profile collapse in certain wireless technology sectors, European venture capital investors have maintained a high level of interest in wireless companies, according to Claudia Wolosin and Liz Barth of Windmill Reports.
Guide to the European life science venture capital industry
Global economic pressures have made venture capital fundraising increasingly challenging in the life sciences sector, according to BioSeeker's guide to the life sciences market. With few exit opportunities, dwindling venture investments and write-offs all too familiar, it is unsurprising that investors are losing confidence in the industry.
US Aurora continues hiring spree with William New as special venture partner
US life science and information technology venture capital firm, Aurora Funds, has recruited William New as special venture partner. New is the third special venture partner the firm has hired within a month.
Israel Money Tree Survey Q1 2003
Israel witnessed a sharp drop in the number of companies raising venture capital in the first quarter of 2003. The market recorded the lowest number of deals since 1998, according to the Kesselman & Kesselman PricewaterhouseCoopers Money Tree Survey.
US Koch Ventures hires Stuart Lodge as partner and chief financial officer
US early-stage private equity firm, Koch Ventures, has hired Stuart Lodge as partner and chief financial officer. Lodge joins as the sixth investment professional.